Praxis Precision Medicines (PRAX) Free Cash Flow (2019 - 2026)
Praxis Precision Medicines (PRAX) posted quarterly Free Cash Flow of -$86.2 million for Q1 2026, down 62.32% year-over-year from -$228.7 million in Q1 2025, and down 12.88% quarter-over-quarter from -$76.3 million in Q4 2025.
Praxis Precision Medicines (PRAX) Free Cash Flow (2019 - 2026) Analysis & Trends
Praxis Precision Medicines' Free Cash Flow history runs 8 years deep, the most recent figure standing at -$86.2 million for Q1 2026.
- In Q1 2026, Free Cash Flow fell 62.32% year-over-year to -$86.2 million; the TTM figure through Mar 2026 stood at -$282.2 million (down 72.1% YoY), while the FY2025 annual figure was -$249.1 million, down 89.08% from the prior year.
- Free Cash Flow for Q1 2026 stood at -$86.2 million, down from -$76.3 million in the prior quarter.
- The five-year high for Free Cash Flow was -$20.9 million in Q1 2024, with the low at -$86.2 million in Q1 2026.
- The 5-year median for Free Cash Flow is -$44.5 million (2022), against an average of -$44.9 million.
- The sharpest annual moves came in 2023 and 2025: Free Cash Flow jumped 47.74% in 2023, then slumped 154.47% in 2025.
- Praxis Precision Medicines' Free Cash Flow stood at -$29.2 million in 2022, then gained by 18.42% to -$23.9 million in 2023, then slumped by 135.2% to -$56.1 million in 2024, then plunged by 36.0% to -$76.3 million in 2025, then fell by 12.88% to -$86.2 million in 2026.
- Business Quant data shows PRAX's Free Cash Flow at -$86.2 million in Q1 2026, -$76.3 million in Q4 2025, and -$65.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.01 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 572.80 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -389.61 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 437.80 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -2.33 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 477.44 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 292.04 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -95.09 Mn |
| 10 | Praxis Precision Medicines | 10.24 Bn | 9.48 Bn | - | -78.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -78.25 Mn |
| Jun 30, 2026 | -78.25 Mn |
| Mar 31, 2026 | -86.15 Mn |
| Mar 31, 2026 | -86.15 Mn |
| Dec 31, 2025 | -76.33 Mn |
| Dec 31, 2025 | -76.33 Mn |
| Sep 30, 2025 | -65.05 Mn |
| Sep 30, 2025 | -65.05 Mn |
| Jun 30, 2025 | -54.68 Mn |
| Jun 30, 2025 | -54.68 Mn |
| Mar 31, 2025 | -53.07 Mn |
| Mar 31, 2025 | -53.07 Mn |
| Dec 31, 2024 | -56.12 Mn |
| Dec 31, 2024 | -56.12 Mn |
| Sep 30, 2024 | -27.50 Mn |
| Sep 30, 2024 | -27.50 Mn |
| Jun 30, 2024 | -27.28 Mn |
| Jun 30, 2024 | -27.28 Mn |
| Mar 31, 2024 | -20.86 Mn |
| Mar 31, 2024 | -20.86 Mn |